| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5331dd9303f28c2e892fe7d7d8339109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4eaf556154d70b81a9b23c1614d7a0db |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-455 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-455 |
| filingDate |
2019-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d9ac9bb742c4d2dd5d4816318b9eaf0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c41e3a6dafd631fbcffce02b511e4346
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ca17c6ad5fbb561a32948be90eda0204
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2894fdc93173fc5741d86d1222ce6958
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dcca13f293aa919130eed6846ac2c455
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ef92c554fb500e3b5c987096624f0e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ddc4ee7fd83499c133b273555ac7eaf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_107923426f5865a0f386cf15a0b673e8 |
| publicationDate |
2021-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210046115-A |
| titleOfInvention |
Niacin derivative and pharmaceutical composition containing the same |
| abstract |
The present specification provides a niacin derivative compound in which side effects are reduced by improving bioavailability and absorption pattern, and a method for preparing the same. The present specification also relates to a pharmaceutical composition containing the niacin derivative compound according to the present specification as an active ingredient and the use of the niacin derivative compound in medicine and health functional food. The present specification also provides a method for treating or ameliorating various diseases and/or symptoms in which niacin can exert an effect, comprising administering to an individual in need of treatment an effective amount of a compound according to the present invention, a salt thereof, or a composition comprising the same. Provides. |
| priorityDate |
2019-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |